Back to Companies
RELMADA THERAPEUTICS, INC.
RLMDNasdaqCIK: 0001553643
Recent Form 4 activity at RELMADA THERAPEUTICS, INC. (RLMD) spans 12 filings across 7 insiders (all of them on the buy side). Purchases total $2.5M against $0 in sales — heavily weighted toward buying, for a net purchase of $2.5M. TRAVERSA SERGIO (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $5.0M by TRAVERSA SERGIO. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$19.5M
Purchases
$2.5M
Sales
$0
Unique Insiders
7
Recent Insider Trades
12 loaded
| Dec 16 | RLMD RELMADA THERAPEUTICS, INC. | CASAMENTO CHARLES J | Director | Award | $665.8K |
| Dec 16 | RLMD RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | Chief Executive Officer, Director | Buy | $113.3K |
| Dec 16 | RLMD RELMADA THERAPEUTICS, INC. | Kelly Paul Edward | COO, Director | Award | $3.4M |
| Dec 16 | RLMD RELMADA THERAPEUTICS, INC. | GLASSPOOL JOHN | Director | Award | $665.8K |
| Dec 16 | RLMD RELMADA THERAPEUTICS, INC. | Shenouda Maged | Chief Financial Officer | Buy | $48.1K |
| Dec 16 | RLMD RELMADA THERAPEUTICS, INC. | Fedeli Fabiana | Director | Award | $665.8K |
| Dec 16 | RLMD RELMADA THERAPEUTICS, INC. | Ence Chuck | CA and CO | Award | $3.4M |
| Nov 6 | RLMD RELMADA THERAPEUTICS, INC. | Kelly Paul Edward | Chief Operating Officer, Director | Buy | $198.0K |
| Nov 6 | RLMD RELMADA THERAPEUTICS, INC. | Shenouda Maged | Chief Financial Officer | Buy | $1.1M |
| Nov 6 | RLMD RELMADA THERAPEUTICS, INC. | Ence Chuck | CAO and COO | Buy | $299.2K |
| Nov 6 | RLMD RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | Chief Executive Officer, Director | Buy | $599.5K |
| Aug 28 | RLMD RELMADA THERAPEUTICS, INC. | TRAVERSA SERGIO | Chief Executive Officer, Director | Buy | $178.1K |
12 filings